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Myocardial viabilityAbstract Background: Assessment of viable myocardium has important prognostic value in
patients with coronary artery disease (CAD). The aim of this study was to compare 3 T cardiac
magnetic resonance (CMR) with single-photon emission computed tomography (SPECT).
Methods: Thirty-three patients with coronary artery disease were involved in this study. All
patients were examined using coronary angiography to determine the degree of the coronary artery
disease. Then, they underwent 3 T CMR examination, after administration of intravenous gadolin-
ium and the segmental extent of myocardial enhancement was determined, followed by SPECT
evaluation. Comparison of myocardial viability was performed in 99 coronary territories.
Results: Agreement between two modalities was obtained in 88 segments (88.9%), resulting in a
kappa value of 0.725. In 99 segments, we had eleven discordant results. Eleven SPECT viable seg-
ments were non-viable according to CMR.
Conclusion: SPECT was comparable to 3 T CMR for myocardial viability assessment, C-MRI
detected more non-viable segments with high definition to the thickness of the myocardial scar tis-
sue than the SPECT.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Not every patient with coronary artery disease (CAD) can
benefit from coronary revascularization so, assessment of
viable myocardium has important prognostic implications.Only patients with a considerable amount of dysfunctional but
viable myocardium benefit from revascularization procedures (1).
Imaging modalities such as positron emission tomography
(PET) in combination with perfusion imaging or single-
photon emission computed tomography (SPECT) have been
used for the detection of myocardial viability (2). These tech-
niques are relatively time-consuming and expose the patient
to radiation.
Table 1 Characteristics of the patient population.
Characteristics Frequency
Number of patients (women) 33
Age (years) 54 (±3.3)
Extent of coronary artery disease
Three vessel disease 4 (12%)
Two vessel disease 15 (45.5%)
One vessel disease 14 (42.5%)
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MRI (CE-MRI) is considered as promising imaging modality
that has been used for the assessment of myocardial viability.
This technique provides direct imaging of necrotic tissue with
high contrast and high spatial resolution (3). In patients with
CAD, the transmural extent of the scar tissue predicts func-
tional recovery after myocardial revascularization. Several
studies suggest that areas of hyperenhancement represent irre-
versible ischemic injury (4).
There are many several advantages of 3 T MR over 1.5 T
MR in cardiac imaging. First, 3 T has high signal-to-noise
ratio (SNR) than 1.5 T that can be used to increase the spatial
resolution or reduce the acquisition time by using parallel
imaging. This issue is so important in better delineation of
myocardial scarring with high image quality (5). In addition,
the high spatial resolution of the 3 T can better discriminate
infarct zones from peri-infarct regions, which may be a focus
of ventricular arrhythmias and has been reported to be a
strong predictor of future cardiovascular events. Second,
the prolongation of the T1-relaxation times at 3.0 T is
expected to improve the tissue enhancing properties of the
T1-shortening contrast agents, and thus can reduce the dose
of the contrast agent in cardiac examination (6). Third, stimu-
lated echo acquisition mode (STEAM) MRI is recently newer
methods at 3 T for black-blood LGE myocardial imaging. This
method enhances the discrimination of the blood-infarct
border than allowing measurement of infarct size accurately.
In contrast, 3 T has strong static field inhomogeneities and
short T2* that cause more artifacts with SSFP cine imaging
than at lower field strengths (7,8).
This study was performed to assess the degree of the agree-
ment between 3 T cardiac MR (CMR) and SPECT myocardial
perfusion imaging (MPI), in the detection of myocardial viability.
2. Patients and methods
2.1. Patients
Thirty-three patients that were clinically diagnosed to have
CAD were enrolled in that study after having their consent.
They all were examined using coronary angiography to localize
the affected coronary artery and to predict the affected
myocardial segments (9).
The age of the patients ranges between 32 and 75 years with
mean age 54 years (±3.3). There were a total number of 29
males and 4 females.
The major inclusion criterion was scheduling for conven-
tional coronary angiography. Other criteria were, sinus heart
rhythm, ability to hold breath for 10–20 s and normal serum
creatinine.
Exclusion criteria were hemodynamic instability, atrial fib-
rillation, contraindications for MR imaging, claustrophobia,
applied pacemaker or metal implants, contraindication for
contrast material including known allergy and renal insuffi-
ciency (serum creatinine more than 1.4 mgndl). Characteristics
of the patient population are shown in Table 1.
2.2. Methods
All patients were subjected to conventional coronary angiogra-
phy, contrast enhanced MRI and SPECT. Written and verbalconsents were obtained from all patients as well as an
agreement of the local ethics committee.
1. Selective Conventional Coronary Angiography: All patients
were scheduled for diagnostic coronary angiography.
Arterial catheterization and selective coronary angiography
were performed within 3 weeks before or after the cardiac
MRI study using a trans-femoral approach to selectively
inject the left and right coronary systems sequentially. Dif-
ferent projections are used according to the standard tech-
niques with at least four views of the left and two views of
the right coronary artery systems were analyzed.
Images analysis: A reduction of the luminal diameter 70%
or more in a major epicardial coronary artery or the
major branches was considered to be a relevant stenosis.
The angiographic results were classified as one-, two-, or
three-vessel disease.
2. SPECT study: Patients underwent 2-day exercise/rest gated
SPECT imaging with Tc-99 m sestamibi to allow adequate
decay of myocardial activity from the first image and to
minimize interference of the first with the second image.
On day 1: Stress study: The patients were instructed to be
fasting and to wear comfortable shoes and loose fitting
clothes. Calcium channel blockers and long acting nitrates
were stopped 24 h before the test while beta blockers were
stopped 48 h before the test. Tc-99 m sestamibi 20–25 mCi
was intravenously injected at peak exercise or after injection
of pharmacological agent and flushed with 5–10 ml saline
solution and then the stress was continued for 1–2 min at
the same workload.
Initial stress imaging was started approximately 30–60 min
after injection. Cardiac gated SPECT was performed. 32 pro-
jection (30 s/projection) images were obtained over 1800 circu-
lar orbit, beginning from the 450 right anterior oblique views
to the 450 left posterior oblique views. The images obtained
were reconstructed as three sets of tomographic images ori-
ented along the standard orthogonal planes of the left
ventricle.
On day 2: Rest study: Patients were fasting for at least 4 h
before the study. Rest gated SPECT imaging was started
60 min after intravenous injection of 20–25 mCi of Tc–
99 m sestamibi and flushed with 5–10 ml saline solution in
the same manner as in the stress study.
The reconstructed data were projected as tomographic
slices in short, vertical and horizontal axis views in side-by-
side display. In addition, the images were displayed as polar
plots (bull’s eye maps).
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(1) All images were reviewed by experienced nuclear
cardiologist.
(2) Quantitative and semi-quantitative analysis from 60 min
poststress and rest SPECT images were performed using
the following:
Scintigraphic indices: A semi-quantitative visual interpreta-
tion was performed using 4 evenly spaced regions in the apical,
midventricular and basal slices of the short axis views and
apical segment on the midventricular long axis slices (17
segments totally).
Each segment was scored using 4-point scoring system (0
indicated normal; 1 mild; 2 moderate; 3 severe reduction of
isotope uptake in segment).
The summed stress and rest score were obtained by adding
the score of the 17 segments of the respective images. These
indices were converted to percent as the total myocardium
(% myocardium) involved with stress, ischemia or fixed defects
by dividing the summed score by 51 the maximal potential
score (3  17), and multiplying by 100.
Comparison between resting and exercise images is used to
detect areas with fixed defects (scar), those with reversible
defects (ischemic but still viable) and those with partially
reversible defects (mixed scar and ischemia).
A defect was considered to be fixed when there was no
change between the stress and rest images, partially reversible
when there was an improvement in tracer uptake of at least
1 grade between stress and rest images, totally reversible when
there was normalization of uptake at rest images.
3. Cardiac MR examination: No special instructions are
required prior to the examination. Medications are not to
be discontinued. All steps of the study were explained in
detail for each patient with given instructions for breath
hold.
A Philips Achiva, the Netherlands (3 T) superconducting
magnet was used. All patients were examined in the supine
position, head first using respiratory sensor and ECG gating.
Additionally sensitivity encoding (SENSE) cardiac coil was
used. All patients received wide bore intravenous line for the
contrast agent. The patients underwent a standard MR exam-
ination that included the following steps:
1. Scout images were acquired in orthogonal orientations for
planning of the final long-axis and short-axis views.
2. First pass rest perfusion imaging by using geometry is iden-
tical to that of the short axis cine views to carefully exclude
any wraparound or trigger artifacts before starting the
actual index test. It is performed by intravenous bolus injec-
tion of 0.025 mmol/kg of gadopentetate dimeglumine
(Magnevist) at an injection rate of 5 mL/s followed by a
flush of 20 mL of saline solution at the same rate. Scanning
was started about 10 s after the starting of contrast injec-
tion and continues for about 1 min. Breath-hold first-pass
perfusion MR imaging was performed by using a hybrid
gradient echo-planar imaging pulse sequence. This pulse
sequence yields three sections (at basal, mid-cavitary and
apical levels) in the short-axis view covering the entire
left ventricle every other heart beat with the followingparameters: TR/TE: 2.9/1.46, FOV: 350  350 mm2,
Phases: 25, NSA: 1, Matrix: 128  128, Bandwidth:
125 kHz, Flip angle: 200, Scan Time: 1 s., Slice thickness:
8 mm, Slice number: 3.
3. An additional bolus of 0.2 mmol/kg gadopentetate dimeglu-
mine immediately after ending of the rest perfusion scan.
4. Functional cine images: These images were acquired using
electrocardiographic gated, breath hold balanced fast field
echo (b-FFE) sequence in short axis view. Stack of eight
to eleven sections in short-axis views, were obtained during
repeated breath-holds, starting from the mitral valve inser-
tion and covering the entire left ventricle with the following
parameters: TR/TE: 4.4/2.5, FOV: 300  300 mm2, Phases:
25, NSA: 1, Matrix: 128  128, Slice thickness: 8 mm, Slice
number: 8–11. This sequence was performed during the
interval period between the aforementioned injection of
additional bolus of contrast and the delayed gadolinium
enhancement sequences.
5. Standard delayed gadolinium enhancement imaging, using
segmental inversion recovery balanced turbo field echo
(IR-b-TFE) was acquired with 10–15 min interval delay after
the last injected intravenous bolus. Contrast-enhanced images
were acquired in short axis plane and at least one of the long
axis planes with the following parameters: TR/TE: 3.8/1.86,
FOV: 300  300 mm2, TI: 260–350, NSA: 1, Matrix:
128  128, Bandwidth: 125 kHz, Flip angle: 15, Scan Time:
9–15 s., Slice thickness: 8 mm, Slice number: 8–11.
The mean time of the MR imaging examination was about
30–35 min.
 Image analysis: Images (DICOM) were transferred to a
workstation equipped with a dedicated cardiac software
package (Brilliance 170 P workstation), for further analysis.
Segmental analysis: Images of delayed enhancement (DE)
on MRI and SPECT were evaluated guided by the results of
the coronary angiography to predict the affected segments
using an identical 17-segment model (5). The basal, mid-
ventricular, and apical segments were evaluated on short-axis
images, whereas the apical cap was evaluated on a 2 or four-
chamber long-axis planes.
Results of cardiac MRI were subdivided into two groups:
(a) Viable myocardial segment: It was defined as no myocar-
dial scarring or 650% myocardial scarring. Subendo-
cardial scarring was defined as 25% myocardial
scarring and partial thickness scarring was defined as
50% myocardial scarring.
(b) Nonviable myocardial segment was defined as >50%
thickness myocardial scarring. A no-reflow zone
(microvascular obstruction) is evident on delayed-
enhancement imaging as a dark region surrounded by
hyperenhancing myocardium and/or first pass resting
perfusional defect corresponding to delayed myocardial
enhancement.
Findings of the cardiac MRI were compared to those of the
corresponding conventional coronary angiograms and
SPECT. The Kappa statistics was used to calculate the level
of agreement between Cardiac MRI and SPECT in the distinc-
tion between viable and non-viable myocardium.
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Fig. 1 35-year-old young male patient with clinical manifestations of CAD. (A) Coronary angiography showing moderately stenotic
lesion at LAD territory, inducing about 40–50% luminal reduction. (B) In the 3D IR sequence, axial & four chamber images, showing
transmural (75–100%) enhancing scar at the left ventricular wall involving anterior, anteroseptal and septal segments at the mid-cavitary
and apical levels and extends to involve the cardiac apex circumferentially). (C) SPECT study was performed that revealed large
transmural myocardial scar along the apex, septum, anterior and inferoapical segments.
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CFig. 2 52-year-old male patient with CAD. (A and B) Conventional coronary angiographic findings: LAD: shows mid course stenotic
lesion, inducing about 60–70% luminal reduction (closed black arrow). LCx: shows proximal and mid portion stenotic lesions, inducing
about 80% luminal reduction for each (opened black arrows). (C) In the delayed 3D IR sequence, there is multifocal patchy areas of
enhancing scar tissue detected involving the following segments: Near transmural scarring along the anterolateral segments at the basal
level and lateral segment at the mid-cavitary level respectively (upper images; right left) (LCx territory). Subendocardial scarring along the
anterior segments at the mid-cavitary and apical levels (lower images; right left) (LAD territory). (D) Gated SPECT shows: Mild to
moderate ischemia at the anterior wall (LAD territory). Stress images in short axis and Bull’ eye images D–F: Rest images in short axis
and Bull’ eye images. The cardiac MRI detected subendocardial scarring along the LAD territory and focal small transmural scar along
LCx territory. The SPECT study detects only ischemic insult along LAD territory. Yet it missed the focal small scar and subendocardial
scar detected by cardiac MRI along the LCx and LAD territories respectively.
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Thirty-three patients were included in the study (characteristics
of the study population are shown in Table 1) with corre-
sponding 99 territories. The morphology, and global andregional ventricular functions were assessed using the func-
tional short axis cine images.
Cardiac MRI detected myocardial segments corresponding
to 23 transmural scarred territories, matching with 12 trans-
mural scarred territories detected by SPECT study (Fig. 1).
DFig. 2 (continued)
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1. Two territories of negative finding in SPECT study cor-
respond to small scar at LCx and RCA territories
detected by MRI (Fig. 2).
2. Two territories of ischemic findings in SPECT study
correspond to scarred myocardial segments along
LAD and LCx territories detected by MRI.
3. Seven territories of partial thickness scarring in SPECT
study correspond to transmural scarred myocardial
segments along LAD, LCx and RCA territories (Fig. 3).
Microvascular obstruction was detected in 5 territories
among these 23 territories of transmural scarring (Fig. 3).
MRI detected myocardial segments corresponding to 9 par-
tial thickness scarred territories, matching with 8 partial thick-
ness scarred territories detected by SPECT study. The
mismatched one territory was negative in SPECT.
SPECT detected myocardial segments corresponding to 15
of partial thickness scarred territories, matching with 8 partial
thickness scarred territories in cardiac MRI. The other mis-
matched 7 territories correspond to 7 transmural scarred terri-
tories in cardiac MRI.
Among the examined 99 territories, subendocardial scarring
of myocardial segments detected in cardiac MRI along 7 territo-
ries. From these diseased territories with subendocardial scarring,
only 1 territory (14%) is matching with SPECT findings, and the
other six territories were negative in SPECT (Fig. 2).
We considered delayed enhancing myocardial segment as
scarred myocardial tissue. Among the 99 examined territories,
variable thickness of myocardial scarring was detected at 39
territories (23 transmural, 9 partial thickness and 7 subendo-
cardial scarring).
 Among the examined 99 territories, cardiac MRI detected
23.2% (23 out of 99) of nonviable (transmural scarred) dis-
eased territories and 76.7% (76 out of 99) with still having
variable degree of viable territory. In 89% of the examined viable and nonviable territories, we
had an agreement between the CE-MRI and SPECT find-
ings. All scarred (nonviable) territories detected by SPECT,
were detected by CE-MRI. However, 11 nonviable territo-
ries detected by CE-MRI were shown to be viable by
SPECT.
 So SPECT viable/CE-MRI non-viable territories were
localized in 11 territories and this accounts for 48% (11
out of 23 nonviable territories) of all nonviable territories
and 11.1% of all the examined territories (Table 2).
In 88.9% of the segments, we had an agreement between
the two methods, which denotes a Kappa value of 0.725.
4. Discussion
In developed countries, coronary artery disease (CAD) contin-
ues to be a major cause of death and disability. Since intro-
duction of the cardiac MRI as a non-invasive tool for
depiction of the coronary artery disease, the clinical value of
myocardial MRI has been the subject for research work. Sev-
eral comparative studies for evaluation of cardiac MRI as a
diagnostic tool for coronary artery disease using the conven-
tional angiography as the gold standard have been published.
The results of these researches concluded that cardiac MRI is
considered as accurate imaging tool in detection of myocardial
viability. Recently developed high field MR magnet (3 T) and
improvements of the used MR protocols allow high spatial
and temporal resolutions with considerably reduced acquisi-
tion times, reflecting on the image quality leading to better
results.
The results of this study demonstrate a high agreement
between CE-MRI and SPECT. It had previously been proved
that 50% of the segmental extent of hyperenhancement in
CE-MRI would be a good discriminator for functional recov-
ery after revascularization (10), so we considered segments
with >50% thickness of myocardial enhancement as non-
viable.
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Fig. 3 62-year-old male patient with clinical manifestations of CAD. (A) Conventional coronary angiography showing total proximal
RCA occlusion that fills faintly distally retrogradely from the left system collaterals (arrows). (B) In the dynamic 2D EPI sequence, the left
ventricular inferior wall shows poorly defined small myocardial perfusional defect at the inferior segment at its basal ventricular level. (C)
Short & long axis cardiac images in the 3D IR sequence, there is transmural (75–100%) enhancing scar seen along the inferior and
inferolateral segments of the left ventricle at its mid-cavitary and basal levels with hypointense filling defect within its core, corresponding
to the fore-mentioned resting perfusional defect, denoting superadded microvascular obstruction. (D) Gated SPECT Findings, shows
Mixed scar and ischemia (predominant scarring) is seen involving most of the inferior wall with partial extension to the apical inferoapical
segment.
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23.2% (23 out of 99) of nonviable (transmural scarred) dis-
eased territories and 76.7% (76 out of 99) with still having
variable degree of viable territory.
All scarred (nonviable) territories detected by SPECT, were
detected by CE-MRI. However, 11 nonviable territories
detected by CE-MRI were shown to be viable by SPECT. So
SPECT viable/CE-MRI non-viable territories were localized
in 11 territories and this accounts for 48% (11 out of 23 non-
viable territories) of all nonviable territories and 11.1% of all
the examined territories.
Agreement between two modalities was obtained in 88
segments (88.9%), resulting in a kappa value of 0.725. The dis-
cordant results can be attributed to both imaging artifacts.
Thinning of the myocardium without irreversible damage
may result in a viability defect in a SPECT study, while
CE-MRI allows determining directly the amount of viable
myocardium within the thin segment (11). Thus, CE-MRImay be especially important in identifying myocardial viability
in patients with a thin myocardial wall (12).
SPECT MPI has many limitations yet it is still widely avail-
able and validated in many cases. Its limitations include long
acquisition time, using radio-active tracer agents, poor spatial
resolution and high limitation in detection of subendocardial
defects (10). The SPECT MPI can be partially degraded also
by many motion artifacts related to the patient, diaphragmatic
and gut motion. Soft tissue photon attenuation artifacts which
are often observed in myocardial SPECT imaging might repre-
sent themselves as myocardial viability defects especially in the
inferior and lateral myocardial wall (13,14). In previous
study, overestimation of infarct size was reported by CE-
MRI 16. This effect could explain some of our discordant
results. The imaging hardware and iterative reconstruction of
the SPECT MPI were developed in last decade, resulting in
improvement of its spatial resolution contrast and imaging
speed (15).
Table 2 Showing the results of ce-MRI and SPECT in the
assessment of myocardial viability.
Comparison of myocardial viability between ce-MRI and SPECT
SPECT (n)
Viable Nonviable
CE-MRI (n) Viable 76 0 76
Nonviable 11 12 23
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vious studies in CAD, the cardiac MR considered as golden
standard technique for proper diagnosis of acute or chronic
MI. Delayed enhancement inversion techniques are considered
the most widely used and accurate tool in differentiation
between reversible and irreversible myocardial ischemic injury.
The delayed enhancement technique has high capability to
detect micro infarcts as little as 1 g of irreversibly damaged tis-
sue (13). In addition, the delayed-enhancement technique has
high sensitivity for identification of both acute (99%) and
chronic (94%) MI and also has 97% accuracy for prediction
of the vascular distribution of the scar (IV). Good correlation
between the delayed-enhancement technique and histopathol-
ogy regarding the detection of myocardial scarring was con-
firmed in previous animal studies (14).
Combination between the rest perfusion and delayed
enhancement could be valuable in detection of coronary artery
disease. In our study, 3 T CMR shows higher accuracy in
assessment of myocardial viability compared to SPECT espe-
cially in the subendocardial and inferior left ventricular loca-
tions. This could be explained by its high spatial resolution,
as the CMR can accurately determine the thickness of scarred
myocardium with high definition within the diseased territory.
CMR is considered superior to single-photon-emission CT
(SPECT) in identifying irreversibly damaged myocardium
because of its high spatial resolution, especially in nonanterior
locations (16). As a result, delayed-enhancement MR imaging
findings are now being incorporated into diagnostic criteria for
imaging patients with MI (17).
In addition, CMR was considered as the modality of
Choice in detection of microvascular obstruction, and it was
detected within 5 diseased territories of transmural scarring
in our study. In patients with a recent AMI, myocardial perfu-
sion studies at rest frequently show the infarct territory perfu-
sion deficit. These defects are subendocardially located and the
transmural extent is variable (15). These defects are caused by
microvascular obstruction in the subendocardium (no-reflow).
Other way to detect microvascular obstruction is the presence
of hypointense filling defect within the core of delayed myocar-
dial enhancement.
This imaging abnormality reflects the impaired diffusion of
the gadolinium tracer into the central core of the infarction.
This finding is related to extensive microvascular obstruction
produced by myocardial infarction that results not only in
myocyte death, but also in extensive microvascular destruc-
tion. The presence of microvascular obstruction has been
shown to correlate with a significantly increased risk of adverse
outcomes from myocardial infarction, including adverse
remodeling, diminished systolic function, and arrhythmia (14).In our clinical practice, the short acquisition times and high
spatial resolution of the 3 T CMR allowed to perform the car-
diac examination in short time with high definition of myocar-
dial scarring. Moreover, 3 T CMR had high capability in
detection of resting perfusional defects or hypointense defects
within the enhanced myocardial scarring. 3 T CMR was feasi-
ble for the routine assessment of myocardial viability with no
need of stress agents or radiation exposure.
Potential role for cardiac MRI as a non-invasive modality
in evaluation of the coronary artery disease, includes the fol-
lowing conditions:
 Detection of diseased coronary territory in patients suspect-
ing or known to have CAD with high sensitivity and
specificity.
 Differentiation between ischemic and dilated
cardiomyopathy.
 The cardiac MR is considered as the most accurate method
for assessment of myocardial viability, delineation and
quantification of myocardial scarring, and thus it is neces-
sary to preoperatively predict the functional recovery.
 Diagnosis of the associated complications of myocardial
infarction (MI) in one examination setting.
 In addition, the time required to perform a viability study
with MRI is usually less than one hour, whereas this time
extends to about 3–24 h for SPECT, which is apparently
an additional benefit of MRI compared with SPECT.
In conclusion, resting cardiac MR shows high accuracy as
compared to stress SPECT study in detection and delineation
of myocardial scarring, particularly the subendocardial scar-
ring in one short time examination.
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